Nature Medicine – Prespecified exploratory genomic and transcriptomic profiling of tumor tissues and circulating tumor DNA from patients with BRAF-V600E-mutant metastatic colorectal cancer who…
Nature Communications – Exceptional points can be realized via engineering gain and loss or unidirectional coupling, as demonstrated in optical platforms. Here, the authors report…
Nature Communications – Guan et al. report a strategy of moisture-triggered selective hydrolysis of Sn4+ into Sn(OH)4, eliminating Sn4 + -induced defects in tin-based perovskites and…
Nature Medicine – In the phase 2 NICHE-3 trial, patients with locally advanced mismatch repair-deficient colon cancer who were treated with neoadjuvant anti-PD1 and anti-LAG3…
Myeloma Paper of the Day, November 15th, suggested by Robert Orlowski / Amie L Fonder, Angela Dispenzieri, cancer, Charalampos Charalampous, David Dingli,
Peptide receptor radionuclide therapy (PRRT) has demonstrated immense promise as a treatment for patients with neuroendocrine tumors (NET) who have somatostatin receptor (SSTR) expression. PRRT…
Journal of Cancer Survivorship – Fear of cancer recurrence (FCR) is not routinely addressed in clinical practice, meaning many cancer survivors forego effective interventions. We…
We are in an era of rapid innovation and transformation in health care delivery, driven by the surging development and deployment of progressively more sophisticated…
Wafik El-Deiry: Great day of interdisciplinary learning at the LCC RNA Biology and Cancer Symposium / cancer, LCC RNA Biology and Cancer Symposium, OncoDaily,
